NCT05329688

Brief Summary

Using randomized control study, explore the effect of novel nutrition education program on the nutrition status and life quality of cancer patients receiving radiotherapy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

November 15, 2022

Status Verified

April 1, 2022

Enrollment Period

2.1 years

First QC Date

April 7, 2022

Last Update Submit

November 13, 2022

Conditions

Keywords

nutritionradiotherapycancer patients

Outcome Measures

Primary Outcomes (4)

  • risk of malnutrition

    Nutrition Risk Screening 2002 is used to assess the risk of malnutrition.

    Week 0, 12

  • BMI

    Body mass index is a measure of body fat based on height and weight that applies to adult men and women. It equals to weight divided by height square.

    Week 0, 12

  • albumin

    level of serum albumin

    Week 0, 12

  • Quality of Life (QOL)

    The QOL was measured by the European Organization for Research and Treatment quality of life version 3 questionnaire (EORTC QLQ-C30) simplified Chinese version. It contains five functional scales (physical, role, cognitive, emotional, and social), three symptoms scales (fatigue, pain, and nausea and vomiting), a global health scale, a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, appetite loss, insomnia, constipation, and diarrhea) and financial impact of the disease. For most items, four response categories from 1 (not at all) to 4 (very much) are employed; two items (overall health, overall quality of life) have response categories ranging from 1 to 7. A high scale score represents a higher response level. Thus a high score for a functional scale, the global health status or overall QOL represents a high or healthy status or a high QOL; however, a high score for the symptom scales represents a high level of symptom.

    Week 0, 12

Secondary Outcomes (2)

  • physical function status

    Week 0, 12

  • Knowledge-Attitude-Practice

    Week 0, 12

Study Arms (2)

Arm A

EXPERIMENTAL

Novel nutrition program : Give nutrition health education every week and regular survey and intervention. The education booklets are made based on the guideline and characteristics of the disease.

Procedure: novel nutrition program

Arm B

ACTIVE COMPARATOR

Routine nutrition education Give nutrition education if the patient visits the clinics. Irregular survey and intervention were given to the patients.

Procedure: novel nutrition program

Interventions

Give nutrition health education every two weeks and regular survey and intervention. The education booklets are made based on the guideline and characteristics of the disease.

Arm AArm B

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients are diagnosed with cancer and receive radiotherapy, especially in head and neck cancer, lung cancer, or esophageal cancer.
  • Patients need nutrition support treatment
  • Informed consent

You may not qualify if:

  • Critical patients or life expectancy \< 12 weeks
  • Patients with severe hepatic cirrhosis, Chronic Obstructive Pulmonary Disease, chronic renal failure, intestinal obstruction, stroke.
  • Unconscious or psychiatric patients
  • Patients with communication problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Szu-Yuan Wu

Taipei, Please Select, 116, Taiwan

Location

MeSH Terms

Conditions

Radiation Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Szu-Yuan Wu

    Asia University, Taiwan

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
single blind (Participant)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: single blind (Participant)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2022

First Posted

April 15, 2022

Study Start

December 1, 2022

Primary Completion

December 30, 2024

Study Completion

December 30, 2025

Last Updated

November 15, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

study completed

Shared Documents
STUDY PROTOCOL
Time Frame
data will become available on June 30 2022.
Access Criteria
requirement with official application

Locations